Effects of recombinant human erythropoietin on the haemopoietic bone marrow monitored by magnetic resonance spectroscopy in patients with end-stage renal disease
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 8 (3) , 237-243
- https://doi.org/10.1016/0730-725x(90)90095-j
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.Radiology, 1989
- In Vivo Measurements of the T1 Relaxation Processes in the Bone Marrow in Patients with Myelodysplastic SyndromeActa Radiologica, 1989
- Localized high‐resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivoMagnetic Resonance in Medicine, 1989
- Prolonged bone marrow T1-relaxation in patients with polycythemia veraMagnetic Resonance Imaging, 1988
- V. Multi-center trial with protocols and prototype test objects for the assessment of MRI equipmentMagnetic Resonance Imaging, 1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Focal fat deposition in axial bone marrow: MR characteristics.Radiology, 1987
- 1H MR Spatially Resolved Spectroscopy of human tissues in situMagnetic Resonance Imaging, 1986
- Rapid NMR imaging of dynamic processes using the FLASII techniqueMagnetic Resonance in Medicine, 1986
- The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo.Journal of Clinical Investigation, 1984